Vantage achieves EU and North American compliance, and internationally recognized pharmaceutical Good Manufacturing Practices (GMP) certifications.
Vantage Hemp Co. Submits a Drug Master File for CBD Distillate to the U.S. Food & Drug Administration
Vantage Hemp Co. further solidifies its position as an industry leader by its announcement of a DMF submission for its CBD distillate to the FDA.
As an active pharmaceutical ingredient (API) manufacturer, Vantage prepares for its DMF submissions to the FDA to support the quality and safety of its products.
The demand for cannabidiol (CBD) is growing fast in the pharmaceutical sector, thanks to increased awareness among consumers about CBD health benefits.